CRIS Current Research Information System

LICASTRO, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.149
AS - Asia 4.324
EU - Europa 3.640
AF - Africa 252
SA - Sud America 236
Continente sconosciuto - Info sul continente non disponibili 146
OC - Oceania 6
Totale 14.753
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.086
VN - Vietnam 1.201
SG - Singapore 1.132
CN - Cina 1.047
GB - Regno Unito 1.025
DE - Germania 501
SE - Svezia 417
UA - Ucraina 360
IT - Italia 353
HK - Hong Kong 258
FR - Francia 238
IN - India 236
RU - Federazione Russa 216
BR - Brasile 168
IE - Irlanda 127
JP - Giappone 91
NL - Olanda 83
KR - Corea 71
ZA - Sudafrica 69
EE - Estonia 62
JO - Giordania 62
CH - Svizzera 59
FI - Finlandia 56
BD - Bangladesh 52
BG - Bulgaria 52
TG - Togo 50
CI - Costa d'Avorio 46
CA - Canada 37
SC - Seychelles 36
TH - Thailandia 31
AR - Argentina 30
PH - Filippine 30
BE - Belgio 29
NG - Nigeria 23
EU - Europa 19
TR - Turchia 18
IQ - Iraq 16
ID - Indonesia 13
GR - Grecia 12
MX - Messico 12
TW - Taiwan 12
AT - Austria 10
CO - Colombia 10
EC - Ecuador 10
PL - Polonia 10
SA - Arabia Saudita 10
LB - Libano 9
ES - Italia 8
CL - Cile 7
MY - Malesia 6
PK - Pakistan 6
AU - Australia 5
KE - Kenya 5
CR - Costa Rica 4
EG - Egitto 4
IR - Iran 4
KZ - Kazakistan 4
MA - Marocco 4
MD - Moldavia 4
PE - Perù 4
IL - Israele 3
LT - Lituania 3
ML - Mali 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
AL - Albania 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ET - Etiopia 2
JM - Giamaica 2
LV - Lettonia 2
OM - Oman 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
SN - Senegal 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
GL - Groenlandia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MM - Myanmar 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 14.624
Salva come PNG Salva come JPEG
Città #
Southend 878
Singapore 776
Fairfield 672
Ashburn 569
Chandler 435
Dong Ket 432
Santa Clara 362
Seattle 332
Woodbridge 328
San Jose 309
Wilmington 278
Jacksonville 269
Houston 258
Hong Kong 246
Cambridge 235
Ann Arbor 213
Princeton 194
Hanoi 188
Ho Chi Minh City 187
Hefei 167
Dublin 127
Boardman 116
Beijing 114
Nanjing 91
Westminster 89
Padova 88
Lauterbourg 85
Tokyo 80
New York 72
Amman 62
Berlin 62
Council Bluffs 61
Los Angeles 59
Seoul 55
Bern 54
Helsinki 53
Sofia 52
Lomé 50
Buffalo 48
Abidjan 45
Mülheim 45
Saint Petersburg 45
Dallas 42
Bremen 40
Shenyang 40
San Diego 39
Da Nang 34
Mahé 33
Bologna 31
Hebei 31
Milan 31
Brussels 29
Jinan 29
São Paulo 29
Haiphong 28
Changsha 27
Jiaxing 25
Nanchang 25
Des Moines 24
Abeokuta 23
Guangzhou 22
Pune 22
Bengaluru 21
Turin 21
Norwalk 20
Dearborn 19
Hangzhou 18
Redondo Beach 17
Tianjin 17
Phoenix 16
Verona 16
Olalla 15
Falkenstein 13
Falls Church 13
Frankfurt am Main 13
Mountain View 13
San Venanzo 13
Bangkok 12
London 12
The Dalles 12
Toronto 12
Zhengzhou 12
Chicago 11
Florence 11
Haikou 11
San Francisco 11
Istanbul 10
Paris 10
Shenzhen 10
Thái Nguyên 10
Brooklyn 9
Kunming 9
Nuremberg 9
Amsterdam 8
Can Tho 8
Munich 8
Denver 7
Hải Dương 7
Lanzhou 7
Medford 7
Totale 9.953
Salva come PNG Salva come JPEG
Nome #
A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease. 240
The 21st century epidemic: Infections as inductors of neuro-degeneration associated with Alzheimer's Disease 239
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. 238
Alzheimer's disease gene signature says: beware of brain viral infections. 233
Gene signature in Alzheimer's disease and environmental factors: the virus chronicle. 231
Altered glycosylation profile of purified plasma ACT from Alzheimer's disease. 230
Blood Inflammatory Proteins and Risk of Incident Depression in the Elderly. 223
Alpha 1 antichymotrypsin genotype is associated with increased risk of prostate carcinoma and PSA levels. 206
Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. 205
ASSOCIAZIONE DEL POLIMORFISMO NELLA REGIONE PROMOTRICE DEL GENE DELL’ALFA-1-ANTI-CHIMOTRIPSINA CON L’IPERTROFIA PROSTATICA BENIGNA ED IL CARCINOMA PROSTATICO 202
Peripheral Inflammatory Markers and Antioxidant Response during the Post-Acute and Chronic Phase after Severe Traumatic Brain Injury. 200
A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease. 199
Apolipoprotein E genotypic frequencies among Down syndrome patients imply early unsuccessful aging for ApoE4 carriers. 197
Pathophysiology of age-related diseases 197
Acute myocardial infarction and proinflammatory gene variants. Ann N Y Acad Sci. 2007 Nov;1119:227-42. 196
ASSOCIATIONS OF THE -174 G/C INTERLEUKIN-6 GENE PROMOTER POLYMORPHISM WITH SERUM INTERLEUKIN -6 AND MORTALITY IN THE ELDERLY 193
Multi factorial interactions in the pathogenesis pathway of Alzheimer's disease: a new risk charts for prevention of dementia. 189
Genetic factors regulating inflammation and DNA methylation associated with prostate cancer. 189
ANTI-DSDNA AUTOANTIBODIES IN SERUM OF DOWN’S SYNDROME PATIENTS 188
Apolipoprotein E e4 allele affects risk of hyperhomocysteinemia in the elderly. 187
Blood inflammatory markers and risk of dementia: the Conselice study of brain aging. 185
Pro-inflammatory genetic profile and familiarity of acute myocardial infarction. 185
Analysis of polymorphisms Leiden Factor V G1691A and prothrombin G20210A as risk factors for acute myocardial infarction. 185
Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains 185
La concomitante presenza degli alleli dell'interleuchina-1beta, dell'interleuchina-6 e dell'apolipoproteina E è associata ad un elevato rischio di infarto al miocardio. 184
Variants in antiviral genes are risk factors for cognitive decline and dementia 183
Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease 182
Homocysteine and folate as risk factors for dementia and Alzheimer Disease. 181
Endogenous sex hormones as risk factors for dementia in elderly men and women. 181
The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzheimer's disease patients. 179
Sharing Pathogenetic Mechanisms between Acute Myocardial Infarction and Alzheimer's Disease as Shown by Partially Overlapping of Gene Variant Profiles. 178
Altered vessel signalling molecules in subjects with Down's syndrome. 176
Herpes virus in Alzheimer's disease: relation to progression of the disease 176
NEOPTERIN LEVELS AND IMMUNE ACTIVATION IN THE BLOOD OF CHILDREN WITH DOWN’S SYNDROME 174
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. 174
Multivariable network associated with cognitive decline and dementia 173
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. 173
Variations in inflammatory genes are associated with periodontitis 173
Gene-gene and gene - clinical factors interaction in acute myocardial infarction: a new detailed risk chart 171
Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients 171
The concomitant presence of polymorphic alleles of interleukin-1beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study. 170
Adipocytokines in Down's syndrome, an atheroma-free model: Role of adiponectin 170
Oxidated low-density lipoproteins (oxLDL) and peroxides in plasma of Down syndrome patients. 168
Immunobiologia, il sistema immunitario in stato di salute e malattia 168
alpha-1-Antichymotrypsin polymorphism in the gene promoter region affects survival and synapsis loss in Alzheimer's disease. 166
The CALHM1 P86L Polymorphism is a Genetic Modifier of Age at Onset in Alzheimer's Disease: a Meta-Analysis Study. 166
Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration. 166
Haplotype of single nucleotide polymorphisms in exon 6 of the MZF-1 gene and Alzheimer's disease. 166
The hydroxy-methyl-glutaryl CoA reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deterioration. 165
Genetic risk profiles for Alzheimer's disease: Integration of APOE genotype and variants that up-regulate inflammation. 163
Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease. 163
LDL RECEPTOR EXPRESSION ON T LYMPHOCYTES IN OLD PATIENTS WITH DOWN’S SYNDROME. 160
ALTERED CYTOKINE AND ACUTE PHASE RESPONSE PROTEIN LEVELS IN THE BLOOD OF CHILDREN WITH DOWN’S SYNDOME: RELATIONSHIP WITH DEMENTIA OF ALZHEIMER’S TYPE 157
Role of prothrombotic polymorphisms in successful or unsuccessful aging. 157
IS IMMUNOTHERAPY AN EFFECTIVE TREATMENT FOR ALZHEIMER’S DISEASE 156
Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: A prospective study. 156
Association between the HLA-A2 allele and Alzheimer's disease. 155
DETERMINATION OF TELOMERE LENGTH BY FLOW-FLORESCENCE IN SITU HYBRIDIZATION IN DOWN’S SYNDROME PATIENTS 154
Elevated plasma levels of alpha-1-antichymotripsin in age-related cognitive decline and Alzheimer's disease; a poential therapeutci target. 153
Association between the interleukin-1beta polymorphisms and Alzheimer's disease: A systematic review and meta-analysis 151
Impaired regulation of immune responses in cognitive decline and Alzheimer's disease: lessons from genetic association studies 150
Polymorphisms of pro-inflammatory genes and Alzheimer's disease risk: A pharmacogenomic approach. 149
Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. 148
Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease. 147
Role of cyclooxygenase-2 and 5-lipoxygenase polymorphisms in Alzheimer's disease in a population from northern Italy: implication for pharmacogenomics. 146
Association between the polymorphism of CCR5 and Alzheimer's disease: results of a study performed on male and female patients from Northern Italy. 145
Tumor necrosis factor-alpha antagonists: differential clinical effects by different biotechnological molecules. 145
Effetti del polimorfismo -174 G>C del gene promotore di interleuchina 6 (IL6) su livelli circolanti di IL6 e rischio di mortalità a 4 anni di follow-up: risultati dal Conselice Study of Brain Aging 142
Does down's syndrome support the homocystein theory of atherosclerosis?experience in elderly subjects with trysomy 21. 140
Polymorphisms of fas gene: relationship with Alzheimer's disease and cognitive decline 138
Predictive diagnostics and personalized medicine for the prevention of chronic degenerative diseases. 138
Effetti del polimorfismo -511 T>C del gene di interleuchina 1-beta (IL1B) e del polimorfismo -174 G>C del gene promotore di interleuchina 6 (IL6) sul rischio di demenza di Alzheimer a 4 anni di follow-up: risultati dal Conselice Sudy of Brain Aging. 137
Outcomes from a program of home care attendance in very frail elderly subjects. 136
Plasma nerve growth factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down syndrome: an interesting pathway. 132
Age-related changes in plasma levels of BDNF in Down syndrome patients. 131
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. 131
TRATTAMENTO PER MIGLIORARE LE PRESTAZIONI COGNITIVE DI PAZIENTI AFFETTI DA DEMENZA DI TIPO ALZHEIMER 126
Compendio di patologia Generale 122
VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment. 121
Impaired Innate Immunity Mechanisms in the Brain of Alzheimer's Disease. 121
Okadaic acid induces apoptosis in Down syndrome fibroblasts. 121
Serum neutrophil gelatinase-B associated lipocalin (NGAL) levels in Down's syndrome patients. 116
Advanced oxidation protein products (AOPP) and high sensitivity C-reactiv protein (hS-CRP) in an 'atheroma free model' : Down's Syndrome. 115
FREE AND BOUND LEPTIN IN PREPUBERTAL CHILDREN WITH DOWN’S SYNDROME AND DIFFERENT DEGREES OF ADIPOSITY 114
SHIP2: a "NEW" insulin pathway target for ageing research. 110
Innate immunity and inflammation in ageing: a key for understanding age-related diseases. 108
Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease. 98
Tumor necrosis-factor-alpha -308 A/G polymorphism is associated with age at onset of Alzheimer's disease. 97
Erytrocyte glycohydrases in subjects with trisomy 21: could down's syndrome be a model of accellerrated ageing? 93
Altered thymic endocrine activity along with impairments of peripheral zinc metabolism and T-lymphocyte populations are associated with myasthenia gravis: A follow-up study 55
Totale 14.753
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.520
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.574 162 43 169 152 145 91 40 116 46 55 319 236
2022/20231.907 210 258 99 231 146 136 52 82 325 141 136 91
2023/2024460 38 71 20 45 51 160 15 20 7 17 3 13
2024/20251.727 32 325 114 129 488 73 95 37 24 90 21 299
2025/20263.722 337 321 410 300 434 199 279 231 731 238 84 158
2026/202757 57 0 0 0 0 0 0 0 0 0 0 0
Totale 14.753